Budget Express 2026

co-presented by

ASSOCIATE SPONSORS

HomeNewsBusinessMoneycontrol ResearchSun Pharma: Traction in select speciality comes as a surprise

Sun Pharma: Traction in select speciality comes as a surprise

Though valuation is still not inexpensive, we see improved trade sentiment for Sun Pharma post results. Sustained traction in speciality will be a key re-rating driver

Anubhav Sahu

November 04, 2020 / 11:56 IST

Sun Pharma: Traction in select speciality comes as a surprise

Revlimid is a blockbuster blood cancer drug with sales of $12.1 billion for BMS in 2020.

Watch Webinar

PRO Panorama

Moneycontrol Pro Panorama | Sunday's Budget brunch gives markets indigestion

Feb 1, 2026 / 05:04 PM IST

For the Budget edition of Moneycontrol Pro Panorama: Budget meets targets but lacks excitement and bold initiatives, corporate tax...
Read Now
PRO Weekender

Moneycontrol Pro Weekender | Samvat 2082: The Will to Rise

Oct 18, 2025 / 10:00 AM IST

After a turbulent Samvat 2081, the markets step into the new year not with fireworks but with quiet resolve and the will to rise
Read Now

Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

Unlock exclusive discounts

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More